BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 28245428)

  • 21. Cellular immunotherapy for soft tissue sarcomas.
    Finkelstein SE; Fishman M; Conley AP; Gabrilovich D; Antonia S; Chiappori A
    Immunotherapy; 2012 Mar; 4(3):283-90. PubMed ID: 22401634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New Strategies in Sarcoma: Linking Genomic and Immunotherapy Approaches to Molecular Subtype.
    Lim J; Poulin NM; Nielsen TO
    Clin Cancer Res; 2015 Nov; 21(21):4753-9. PubMed ID: 26330427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The future of immunotherapy for sarcoma.
    Tsukahara T; Emori M; Murata K; Mizushima E; Shibayama Y; Kubo T; Kanaseki T; Hirohashi Y; Yamashita T; Sato N; Torigoe T
    Expert Opin Biol Ther; 2016 Aug; 16(8):1049-57. PubMed ID: 27158940
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Next frontiers in systemic therapy for soft tissue sarcoma.
    Yen CC; Chen TW
    Chin Clin Oncol; 2018 Aug; 7(4):43. PubMed ID: 30173533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of Immunotherapy in Sarcomas.
    Dalal S; Shan KS; Thaw Dar NN; Hussein A; Ergle A
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38279265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeted and immuno-based therapies in sarcoma: mechanisms and advances in clinical trials.
    Tang F; Tie Y; Wei YQ; Tu CQ; Wei XW
    Biochim Biophys Acta Rev Cancer; 2021 Dec; 1876(2):188606. PubMed ID: 34371128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunotherapeutic approaches to sarcoma.
    Linehan DC; Bowne WB; Lewis JJ
    Semin Surg Oncol; 1999; 17(1):72-7. PubMed ID: 10402640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emerging trends in immunotherapy for pediatric sarcomas.
    Dyson KA; Stover BD; Grippin A; Mendez-Gomez HR; Lagmay J; Mitchell DA; Sayour EJ
    J Hematol Oncol; 2019 Jul; 12(1):78. PubMed ID: 31311607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Knowing the myeloid-derived suppressor cells: Another enemy of sarcomas patients.
    García-Domínguez DJ; Sánchez-Margalet V; de la Cruz-Merino L; Hontecillas-Prieto L
    Int Rev Cell Mol Biol; 2023; 375():93-116. PubMed ID: 36967155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is immunotherapy in the future of therapeutic management of sarcomas?
    Clemente O; Ottaiano A; Di Lorenzo G; Bracigliano A; Lamia S; Cannella L; Pizzolorusso A; Di Marzo M; Santorsola M; De Chiara A; Fazioli F; Tafuto S
    J Transl Med; 2021 Apr; 19(1):173. PubMed ID: 33902630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adoptive cell therapy for sarcoma.
    Mata M; Gottschalk S
    Immunotherapy; 2015; 7(1):21-35. PubMed ID: 25572477
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune Therapy for Sarcomas.
    Anderson PM
    Adv Exp Med Biol; 2017; 995():127-140. PubMed ID: 28321815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sarcoma Immunotherapy: Confronting Present Hurdles and Unveiling Upcoming Opportunities.
    Jeong S; Afroz S; Kang D; Noh J; Suh J; Kim JH; You HJ; Kang HG; Kim YJ; Kim JH
    Mol Cells; 2023 Oct; 46(10):579-588. PubMed ID: 37853684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunotherapy in soft-tissue sarcoma.
    Ayodele O; Razak ARA
    Curr Oncol; 2020 Feb; 27(Suppl 1):17-23. PubMed ID: 32174754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Role of Immunotherapy in the Management of Soft Tissue Sarcomas: Current Landscape and Future Outlook.
    Banks LB; D'Angelo SP
    J Natl Compr Canc Netw; 2022 Jul; 20(7):834-844. PubMed ID: 35830892
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adult human sarcomas. II. Medical oncology.
    Sinkovics JG
    Expert Rev Anticancer Ther; 2007 Feb; 7(2):183-210. PubMed ID: 17288529
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of Virus-Directed Therapy in Soft Tissue Sarcoma.
    Chaudhary H; D'Angelo S
    Curr Treat Options Oncol; 2022 Mar; 23(3):404-414. PubMed ID: 35258792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Facts and Hopes in Immunotherapy of Soft-Tissue Sarcomas.
    Martín-Broto J; Moura DS; Van Tine BA
    Clin Cancer Res; 2020 Nov; 26(22):5801-5808. PubMed ID: 32601077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunity against soft-tissue sarcomas.
    Maki RG
    Curr Oncol Rep; 2003 Jul; 5(4):282-7. PubMed ID: 12781069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunotherapy in Sarcoma: Where Do Things Stand?
    Moreno Tellez C; Leyfman Y; D'Angelo SP; Wilky BA; Dufresne A
    Surg Oncol Clin N Am; 2022 Jul; 31(3):381-397. PubMed ID: 35715140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.